164 related articles for article (PubMed ID: 19748785)
1. Design, synthesis, and X-ray crystal structures of 2,4-diaminofuro[2,3-d]pyrimidines as multireceptor tyrosine kinase and dihydrofolate reductase inhibitors.
Gangjee A; Li W; Lin L; Zeng Y; Ihnat M; Warnke LA; Green DW; Cody V; Pace J; Queener SF
Bioorg Med Chem; 2009 Oct; 17(20):7324-36. PubMed ID: 19748785
[TBL] [Abstract][Full Text] [Related]
2. Novel 5-substituted, 2,4-diaminofuro[2,3-d]pyrimidines as multireceptor tyrosine kinase and dihydrofolate reductase inhibitors with antiangiogenic and antitumor activity.
Gangjee A; Zeng Y; Ihnat M; Warnke LA; Green DW; Kisliuk RL; Lin FT
Bioorg Med Chem; 2005 Sep; 13(18):5475-91. PubMed ID: 16039863
[TBL] [Abstract][Full Text] [Related]
3. 2,4-Diamino-5-methyl-6-substituted arylthio-furo[2,3-d]pyrimidines as novel classical and nonclassical antifolates as potential dual thymidylate synthase and dihydrofolate reductase inhibitors.
Gangjee A; Jain HD; Phan J; Guo X; Queener SF; Kisliuk RL
Bioorg Med Chem; 2010 Jan; 18(2):953-61. PubMed ID: 20056546
[TBL] [Abstract][Full Text] [Related]
4. Preferential selection of isomer binding from chiral mixtures: alternate binding modes observed for the E and Z isomers of a series of 5-substituted 2,4-diaminofuro[2,3-d]pyrimidines as ternary complexes with NADPH and human dihydrofolate reductase.
Cody V; Piraino J; Pace J; Li W; Gangjee A
Acta Crystallogr D Biol Crystallogr; 2010 Dec; 66(Pt 12):1271-7. PubMed ID: 21123866
[TBL] [Abstract][Full Text] [Related]
5. Effect of C9-methyl substitution and C8-C9 conformational restriction on antifolate and antitumor activity of classical 5-substituted 2,4-diaminofuro[2,3-d]pyrimidines.
Gangjee A; Zeng Y; McGuire JJ; Kisliuk RL
J Med Chem; 2000 Aug; 43(16):3125-33. PubMed ID: 10956221
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of N-[4-[1-ethyl-2-(2,4-diaminofuro[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic acid as an antifolate.
Gangjee A; Zeng Y; McGuire JJ; Kisliuk RL
J Med Chem; 2002 Apr; 45(9):1942-8. PubMed ID: 11960504
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and X-ray crystal structure of a potent dual inhibitor of thymidylate synthase and dihydrofolate reductase as an antitumor agent.
Gangjee A; Yu J; McGuire JJ; Cody V; Galitsky N; Kisliuk RL; Queener SF
J Med Chem; 2000 Oct; 43(21):3837-51. PubMed ID: 11052789
[TBL] [Abstract][Full Text] [Related]
8. Selective Pneumocystis carinii dihydrofolate reductase inhibitors: design, synthesis, and biological evaluation of new 2,4-diamino-5-substituted-furo[2,3-d]pyrimidines.
Gangjee A; Guo X; Queener SF; Cody V; Galitsky N; Luft JR; Pangborn W
J Med Chem; 1998 Apr; 41(8):1263-71. PubMed ID: 9548816
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and X-ray crystal structure of classical and nonclassical 2-amino-4-oxo-5-substituted-6-ethylthieno[2,3-d]pyrimidines as dual thymidylate synthase and dihydrofolate reductase inhibitors and as potential antitumor agents.
Gangjee A; Li W; Kisliuk RL; Cody V; Pace J; Piraino J; Makin J
J Med Chem; 2009 Aug; 52(15):4892-902. PubMed ID: 19719239
[TBL] [Abstract][Full Text] [Related]
10. Novel non-classical C9-methyl-5-substituted-2,4-diaminopyrrolo[2,3-d]pyrimidines as potential inhibitors of dihydrofolate reductase and as anti-opportunistic agents.
Gangjee A; Yang J; Queener SF
Bioorg Med Chem; 2006 Dec; 14(24):8341-51. PubMed ID: 17010625
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, biological evaluation and X-ray crystal structure of novel classical 6,5,6-tricyclic benzo[4,5]thieno[2,3-d]pyrimidines as dual thymidylate synthase and dihydrofolate reductase inhibitors.
Zhang X; Zhou X; Kisliuk RL; Piraino J; Cody V; Gangjee A
Bioorg Med Chem; 2011 Jun; 19(11):3585-94. PubMed ID: 21550809
[TBL] [Abstract][Full Text] [Related]
12. The Z isomer of 2,4-diaminofuro[2,3-d]pyrimidine antifolate promotes unusual crystal packing in a human dihydrofolate reductase ternary complex.
Cody V; Pace J; Lin L; Gangjee A
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2009 Aug; 65(Pt 8):762-6. PubMed ID: 19652333
[TBL] [Abstract][Full Text] [Related]
13. Structural studies provide clues for analog design of specific inhibitors of Cryptosporidium hominis thymidylate synthase-dihydrofolate reductase.
Kumar VP; Cisneros JA; Frey KM; Castellanos-Gonzalez A; Wang Y; Gangjee A; White AC; Jorgensen WL; Anderson KS
Bioorg Med Chem Lett; 2014 Sep; 24(17):4158-61. PubMed ID: 25127103
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and biological evaluation of substituted pyrrolo[2,3-d]pyrimidines as multiple receptor tyrosine kinase inhibitors and antiangiogenic agents.
Gangjee A; Namjoshi OA; Yu J; Ihnat MA; Thorpe JE; Warnke LA
Bioorg Med Chem; 2008 May; 16(10):5514-28. PubMed ID: 18467105
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and biological evaluation of 2,4-diamino-5-methyl-6-substituted-pyrrolo[2,3-d]pyrimidines as dihydrofolate reductase inhibitors.
Gangjee A; Lin X; Queener SF
J Med Chem; 2004 Jul; 47(14):3689-92. PubMed ID: 15214795
[TBL] [Abstract][Full Text] [Related]
16. Effect of bridge region variation on antifolate and antitumor activity of classical 5-substituted 2,4-diaminofuro[2,3-d]pyrimidines.
Gangjee A; Devraj R; McGuire JJ; Kisliuk RL
J Med Chem; 1995 Sep; 38(19):3798-805. PubMed ID: 7562910
[TBL] [Abstract][Full Text] [Related]
17. 2,4-diamino-5-deaza-6-substituted pyrido[2,3-d]pyrimidine antifolates as potent and selective nonclassical inhibitors of dihydrofolate reductases.
Gangjee A; Vasudevan A; Queener SF; Kisliuk RL
J Med Chem; 1996 Mar; 39(7):1438-46. PubMed ID: 8691474
[TBL] [Abstract][Full Text] [Related]
18. New 2,4-diamino-5-(2',5'-substituted benzyl)pyrimidines as potential drugs against opportunistic infections of AIDS and other immune disorders. Synthesis and species-dependent antifolate activity.
Rosowsky A; Forsch RA; Sibley CH; Inderlied CB; Queener SF
J Med Chem; 2004 Mar; 47(6):1475-86. PubMed ID: 14998335
[TBL] [Abstract][Full Text] [Related]
19. 2,4-Diaminothieno[2,3-d]pyrimidine lipophilic antifolates as inhibitors of Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase.
Rosowsky A; Papoulis AT; Queener SF
J Med Chem; 1997 Oct; 40(22):3694-9. PubMed ID: 9357537
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and antifolate activity of new analogues of piritrexim and other diaminopyrimidine dihydrofolate reductase inhibitors with omega-carboxyalkoxy or omega-carboxy-1-alkynyl substitution in the side chain.
Chan DC; Fu H; Forsch RA; Queener SF; Rosowsky A
J Med Chem; 2005 Jun; 48(13):4420-31. PubMed ID: 15974594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
